An overview of ivabradine
This article provides an overview of the therapeutic effects of ivabradine in the treatment of coronary artery disease (CAD), and in the management of stable angina pectoris (SAP) and congestive cardiac failure (CCF). Patients with SAP have a reduced quality of life and are unable to work efficientl...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2016-12-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/4572 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849329853625532416 |
|---|---|
| author | Tumelo Ramoleta Natalie Schellack Elmien Bronkhorst |
| author_facet | Tumelo Ramoleta Natalie Schellack Elmien Bronkhorst |
| author_sort | Tumelo Ramoleta |
| collection | DOAJ |
| description | This article provides an overview of the therapeutic effects of ivabradine in the treatment of coronary artery disease (CAD), and in the management of stable angina pectoris (SAP) and congestive cardiac failure (CCF). Patients with SAP have a reduced quality of life and are unable to work efficiently, resulting in the increased use of healthcare resources. Unlike the other antianginal drugs (i.e. the beta-blockers, calcium-channel blockers and organic nitrates), ivabradine specifically targets the If current of the sinus node. It reduces the frequency of angina attacks and increases the time until symptoms during work appear. Clinical evidence has shown that ivabradine is an effective anti-ischaemic and antianginal agent, comparable to the beta-blockers and calcium-channel antagonist in controlling the symptoms of myocardial ischemia. |
| format | Article |
| id | doaj-art-61805357e7084c87b3b9155e9a53336a |
| institution | Kabale University |
| issn | 2078-6190 2078-6204 |
| language | English |
| publishDate | 2016-12-01 |
| publisher | AOSIS |
| record_format | Article |
| series | South African Family Practice |
| spelling | doaj-art-61805357e7084c87b3b9155e9a53336a2025-08-20T03:47:09ZengAOSISSouth African Family Practice2078-61902078-62042016-12-01586363910.4102/safp.v58i6.45723668An overview of ivabradineTumelo Ramoleta0Natalie Schellack1Elmien Bronkhorst2Sefako Makgatho Health Sciences UniversitySefako Makgatho Health Sciences UniversitySefako Makgatho Health Sciences UniversityThis article provides an overview of the therapeutic effects of ivabradine in the treatment of coronary artery disease (CAD), and in the management of stable angina pectoris (SAP) and congestive cardiac failure (CCF). Patients with SAP have a reduced quality of life and are unable to work efficiently, resulting in the increased use of healthcare resources. Unlike the other antianginal drugs (i.e. the beta-blockers, calcium-channel blockers and organic nitrates), ivabradine specifically targets the If current of the sinus node. It reduces the frequency of angina attacks and increases the time until symptoms during work appear. Clinical evidence has shown that ivabradine is an effective anti-ischaemic and antianginal agent, comparable to the beta-blockers and calcium-channel antagonist in controlling the symptoms of myocardial ischemia.https://safpj.co.za/index.php/safpj/article/view/4572ivabradineif currentsinus nodecongestive cardiac failureangina pectorisantianginal agent |
| spellingShingle | Tumelo Ramoleta Natalie Schellack Elmien Bronkhorst An overview of ivabradine South African Family Practice ivabradine if current sinus node congestive cardiac failure angina pectoris antianginal agent |
| title | An overview of ivabradine |
| title_full | An overview of ivabradine |
| title_fullStr | An overview of ivabradine |
| title_full_unstemmed | An overview of ivabradine |
| title_short | An overview of ivabradine |
| title_sort | overview of ivabradine |
| topic | ivabradine if current sinus node congestive cardiac failure angina pectoris antianginal agent |
| url | https://safpj.co.za/index.php/safpj/article/view/4572 |
| work_keys_str_mv | AT tumeloramoleta anoverviewofivabradine AT natalieschellack anoverviewofivabradine AT elmienbronkhorst anoverviewofivabradine AT tumeloramoleta overviewofivabradine AT natalieschellack overviewofivabradine AT elmienbronkhorst overviewofivabradine |